NasdaqCM - Delayed Quote USD

Bullfrog AI Holdings, Inc. (BFRGW)

Compare

0.5136

+0.0136

+(2.72%)

At close: January 10 at 4:00:00 PM EST

BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week

GAITHERSBURG, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its participation in the TechBio track at Biotech Showcase and RESI JPM, both taking place during the annual JP Morgan Healthcare Conference in San Francisco, January 13–16, 2

GlobeNewswire yesterday

BFRG
-5.36%
BFRGW
+2.72%
Bullfrog AI CEO: 2025 focus will remain on AI-driven solution commercialization

BullFrog AI (BFRG) Holdings issued a letter to stockholders from its CEO Vin Singh, which read in part, “In thinking back on this past year, it is evident that 2024 was a year of significant progress for BullFrog AI. It was a year of major advancements, strategic collaborations, and impactful discoveries, all of which have set the stage for what promises to be an even more exciting 2025. Our efforts have solidly positioned us for growth in AI-driven drug discovery, while also expanding our capab

TipRanks 14 days ago

BFRG
-5.36%
BFRGW
+2.72%
BullFrog AI Issues Letter to Stockholders

GAITHERSBURG, Md., Dec. 27, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, issued a letter to stockholders from its CEO Vin Singh. Dear Fellow Stockholders, As the year comes to a close, I want to extend my deepest gratitude for your unwavering support and belief in

GlobeNewswire 15 days ago

BFRG
-5.36%
BFRGW
+2.72%
BullFrog AI Announces Appointment of Chief Financial Officer

GAITHERSBURG, Md., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of Josh Blacher as its Chief Financial Officer (CFO), effective immediately. This appointment comes in the wake of the untimely passing of Dane Saglio, BullFro

GlobeNewswire 25 days ago

BFRG
-5.36%
BFRGW
+2.72%
Bullfrog AI Holdings, Inc. (BFRG) to Showcase Breakthrough AI-Driven Drug Discovery Innovations at Google’s Inaugural Cancer AI Symposium

We recently compiled a list of the 20 AI News Investors Should Not Miss. In this article, we are going to take a look at where Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) stands against the other AI stocks you should not miss. 2024 has been a big year for AI breakthroughs, and the momentum shows no signs […]

Insider Monkey 2 months ago

BFRGW
+2.72%
BullFrog AI’s VP Artificial Intelligence to Present at Google’s Cancer AI Symposium

GAITHERSBURG, Md., Oct. 22, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its VP Artificial Intelligence, Enrique García-Rivera, Ph.D., will present at Google’s inaugural Cancer AI Symposium on October 30, 2024, at the Boston Center for the Arts. Dr. García-

GlobeNewswire 2 months ago

BFRG
-5.36%
BFRGW
+2.72%
WallachBeth Capital Announces Closing of Bullfrog AI Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced today it has closed its previously announced definitive agreement for the purchase and sale of an aggregate of 1,565

PR Newswire 2 months ago

BFRG
-5.36%
BFRGW
+2.72%
Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

GAITHERSBURG, Md., Oct. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced today it has closed its previously announced definitive agreement for the purchase and sale of an aggregate of 1,565,000 shares of common stock (or common stock equivalents in lieu t

GlobeNewswire 2 months ago

BFRG
-5.36%
BFRGW
+2.72%
WallachBeth Capital Announce Pricing of Bullfrog AI's Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, has entered into a definitive agreement for the purchase and sale of an aggregate of 1,565,000 shares of common stock (or common

PR Newswire 2 months ago

BFRG
-5.36%
BFRGW
+2.72%
Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

GAITHERSBURG, Md., Oct. 18, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced today it has entered into a definitive agreement for the purchase and sale of an aggregate of 1,565,000 shares of common stock (or common stock equivalents in lieu thereof) in a regi

GlobeNewswire 2 months ago

BFRG
-5.36%
BFRGW
+2.72%
BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

GAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of John Baldoni, Ph.D., to its Scientific Advisory Board. Dr. Baldoni brings over four decades of experience in the pharmaceutical industry, including leadership roles

GlobeNewswire 2 months ago

BFRG
-5.36%
BFRGW
+2.72%
BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114

The study, led by Dr. Lopa Mishra and published in Cell Reports, provides new mechanistic evidence for role of BF-114 target β2-spectrin in obesity, MASLD, MASH, and HCCThe findings suggest that targeting β2-spectrin with BF-114 can prevent the progression of liver diseasesNew data builds on earlier studies and further supports BF-114’s potential to address major unmet needs in treating obesity-related liver diseasesDr. Lopa Mishra, a globally recognized expert in liver disease, has joined BullF

GlobeNewswire 3 months ago

BFRG
-5.36%
BFRGW
+2.72%
Bullfrog AI Holdings, Inc. (BFRG) Revolutionizes Drug Development with AI-Driven bfLEAP Platform and Advances Psychiatric Research Through LIBD Partnership

We recently compiled a list of the 20 Hidden Gem AI Stocks. In this article, we are going to take a look at where Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) stands against the other hidden gem AI stocks. The rise of artificial intelligence (AI) businesses has loomed large over finance markets in the past few months, pushing […]

Insider Monkey 3 months ago

BFRGW
+2.72%
BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

GAITHERSBURG, Md., Aug. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a leader in AI-driven drug discovery, announced today that the Company will participate in the H.C. Wainwright 26th Annual Global Investment Conference being held in New York City. Interested parties may access live and archived webcasts of these events on the company’s investor relations website at: investors.bullfrogai.com. The Company’s presentation by Vin Si

GlobeNewswire 4 months ago

BFRG
-5.36%
BFRGW
+2.72%
BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets

Discussions underway for drug target discovery deals with potential pharma partnersGAITHERSBURG, Md., July 25, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a leader in AI-driven drug discovery, announced significant advancements in its ongoing collaboration with the Lieber Institute for Brain Development (LIBD). Building on the progress detailed in our May 16, 2024 release, our research has now pinpointed specific molecular pathways

GlobeNewswire 5 months ago

BFRG
-5.36%
BFRGW
+2.72%
Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12

GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, is pleased to invite investors to a webinar on June 12, 2024, at 4:15 p.m. ET. To register for the free webinar, please visit: https://redchip.zoom.us/webinar/register/WN_mue5XBuOSOiW5ZqV2iiKeg#/regist

GlobeNewswire 7 months ago

BFRG
-5.36%
BFRGW
+2.72%
BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

GAITHERSBURG, Md., May 16, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug discovery company using artificial intelligence (AI) and machine learning to enable the successful discovery and development of pharmaceuticals and biologics, today announced significant advancements in its collaboration with the Lieber Institute for Brain Development (LIBD), including the identification of potential drug targets for mul

GlobeNewswire 7 months ago

BFRG
-5.36%
BFRGW
+2.72%
BullFrog AI and GreenPower Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / April 26, 2024 / RedChip Companies will air interviews with BullFrog AI Holdings, Inc. (NASDAQ:BFRG) and GreenPower Motor Company Inc. (NASDAQ:GP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg ...

ACCESSWIRE 8 months ago

BFRG
-5.36%
BFRGW
+2.72%
GP
BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo

GAITHERSBURG, Md., April 09, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that its Chief Scientific Officer (CSO), Tom Chittenden, will be presenting at the Quantum Computing Symposium during the Bio-IT World Conference & Expo in Boston on April 15

GlobeNewswire 8 months ago

BFRG
-5.36%
BFRGW
+2.72%
CEO and 10% Owner Vininder Singh Sells 50,000 Shares of Bullfrog AI Holdings Inc (BFRG)

Vininder Singh, CEO and 10% Owner of Bullfrog AI Holdings Inc (NASDAQ:BFRG), executed a sale of 50,000 shares in the company on April 2, 2024, according to a recent SEC Filing.

GuruFocus.com 9 months ago

BFRGW
+2.72%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bullfrog AI Holdings, Inc. (BFRGW)

BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week

Bullfrog AI CEO: 2025 focus will remain on AI-driven solution commercialization

BullFrog AI Issues Letter to Stockholders

BullFrog AI Announces Appointment of Chief Financial Officer

Bullfrog AI Holdings, Inc. (BFRG) to Showcase Breakthrough AI-Driven Drug Discovery Innovations at Google’s Inaugural Cancer AI Symposium

BullFrog AI’s VP Artificial Intelligence to Present at Google’s Cancer AI Symposium

WallachBeth Capital Announces Closing of Bullfrog AI Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

WallachBeth Capital Announce Pricing of Bullfrog AI's Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114

Bullfrog AI Holdings, Inc. (BFRG) Revolutionizes Drug Development with AI-Driven bfLEAP Platform and Advances Psychiatric Research Through LIBD Partnership

BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets

Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12

BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

BullFrog AI and GreenPower Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo

CEO and 10% Owner Vininder Singh Sells 50,000 Shares of Bullfrog AI Holdings Inc (BFRG)